An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation

Published:2024-09-01 Issue:9 Volume:44 Page:414-423
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Safaie Tahmineh¹^ORCID,Trinh Kham R.¹,Vasuthasawat Alex¹,Morrison Sherie L.²,Stover David R.¹

Affiliation:

1. Nammi Therapeutics, Los Angeles, California, USA.

2. Department of Microbiology, Immunology and Molecular Genetics, University of California Los Angeles, Los Angeles, California, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/jir.2024.0099

Reference33 articles.

1. Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications

2. Novel epitope evoking CD138 antigen‐specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders

3. Interferon-alpha in tumor immunity and immunotherapy

4. Cytokine engineering for targeted cancer immunotherapy

5. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP